Europe
2021 is off to a hopeful start for some companies, executives and scientists, while others are forced to fold programs and recalibrate.
With COVID-19 still running rampant across the globe, Moderna announced it will rapidly expand its vaccine manufacturing operations in order to meet demand in the countries where the medication has received emergency authorization.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
Dr. Lynn Seely bows out as Myovant pivots to commercialize new drug.
The U.K authorized AstraZeneca’s COVID-19 vaccine on Wednesday, but it could be April at the earliest before the drug will likely be administered in the United States, Operation Warp Speed’s chief said.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Overnight, U.K. health authorities authorized the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use.
The United Kingdom is expected to give the green light to the vaccine developed by AstraZeneca and Oxford University this week.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Even with the holidays among us, there were a number of clinical trial announcements. Here’s a look.
PRESS RELEASES